VAERS Explorer
Back to explore

Report #2863272

Received Oct 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
GA
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLULAVAL)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (1)

Product quality issue

Symptom narrative

more air than usual in the flu vaccines and they are uncomfortable administering it without removing the bubble; This non-serious case was reported by a nurse via sales rep and described the occurrence of poor quality product administered in a patient who received Flu Seasonal TIV Quebec (FluLaval 2025-2026 season) for prophylaxis. On an unknown date, the patient received FluLaval 2025-2026 season. On an unknown date, an unknown time after receiving FluLaval 2025-2026 season, the patient experienced poor quality product administered (Verbatim: more air than usual in the flu vaccines and they are uncomfortable administering it without removing the bubble). The outcome of the poor quality product administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-SEP-2025 Nurse reported that had noted there seems to be more air than usual in the flu vaccines and they are uncomfortable administering it without removing the bubble, which led to poor quality product administered. Batch number "UNK" and follow-up has been requested: The batch number was not provided and a request for this information has been made.